Dr. Ricardo Cubedo describes 3 research highlights from the ESMO 2019 Congress, including targeted therapy for ovarian cancer, immunotherapy for lung cancer, and more study data on targeted tumor-agnostic treatment. Read More >>
targeted therapy
November 14, 2019 · Greg Guthrie, ASCO staff
September 17, 2019 · Sonja Hibbs
Learn how tumor marker tests can help doctors diagnose cancer and plan the best possible treatment plan for each person. Read More >>
June 3, 2019 · Greg Guthrie, ASCO staff
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include minimally invasive surgery for liver metastases in colorectal cancer, expanding clinical trial eligibility criteria for non-small cell lung cancer, and a new targeted therapy for advanced bladder cancer. Read More >>
June 2, 2019 · Monika Sharda, ASCO staff
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include an effective medication for metastatic prostate cancer, targeted therapy that slows the growth of metastatic pancreatic cancer, how socioeconomic factors may affect survival for multiple myeloma, and how the ACA resulted in earlier treatment and improved equality in care. Read More >>
June 1, 2019 · Monika Sharda, ASCO staff
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include treatment advances for advanced lung cancer, stomach cancer, gastroesophageal junction cancer, and breast cancer. Read More >>